Newsletter MATWIN June 2023
stephanie.dhont2023-06-12T14:33:52+02:00Download here the latest MATWIN newsletter :
June 2023
MATWIN – PSCC partnership – Interview Benjamin Garel
stephanie.dhont2023-06-08T13:08:56+02:00Interview of Benjamin GAREL, General Manager of Paris Saclay Cancer [...]
MATWIN is hiring a R&D Project Manager (Oncology)
stephanie.dhont2023-06-08T13:10:05+02:00You dream of taking part in an exciting and meaningful [...]
MATWIN BOARD MEETING 2023
stephanie.dhont2023-06-02T15:54:04+02:00A unique committee in Europe, the MATWIN Board is made [...]
May 2023
PR: MATWIN highlights about thirty innovative projects to tackle cancer
stephanie.dhont2023-05-16T08:51:06+02:00Download the press release:
PR: MATWIN and the Paris Saclay Cancer Cluster join their forces to accelerate innovation in the fight against cancer
stephanie.dhont2023-05-09T10:57:42+02:00MATWIN and the Paris Saclay Cancer Cluster join their forces [...]
February 2023
BIPER THERAPEUTICS RAISES €1.25 MILLION
stephanie.dhont2023-02-14T12:07:14+01:00BiPer Therapeutics, awarded during OUI (Oncology Upward Investment) 2021 edition [...]
Partnership MATWIN and European Health Investor Network
stephanie.dhont2023-02-02T10:48:11+01:00MATWIN and the European Health Investor Network announce their new [...]
Genoscience Pharma receives FDA orphan drug designation for ezurpimtrostat to treat hepatocellular carcinoma
stephanie.dhont2023-02-01T14:21:34+01:00Genoscience Pharma, supported by MATWIN in 2021, receives FDA orphan [...]
January 2023
First US leukemia patient dosed with investigational SMART101 cell therapy
stephanie.dhont2023-01-23T15:07:55+01:00Smart Immune announced today that the first adult leukemia patient [...]